mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.2 |